The Impact of SARS-CoV-2 Immune Status and Societal Restrictions in Controlling COVID-19 across the World

被引:0
|
作者
Stroo, Jasmijn [1 ]
Lepolder, Michaela [1 ]
Murk, Jean-Luc [2 ]
Rijkers, Ger T. [1 ]
机构
[1] Univ Coll Roosevelt, Sci Dept, NL-4331 CB Middelburg, Netherlands
[2] St Elizabeth Hosp, Microvida Lab Med Microbiol & Immunol, NL-5022 GC Tilburg, Netherlands
关键词
COVID pass; SARS-CoV-2 antigen test; SARS-CoV-2; antibodies; societal restrictions;
D O I
10.3390/vaccines11091407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To control the COVID-19 pandemic, many countries implemented vaccination and imposed societal restrictions both at the national level and for international travel. As a check of corona status, COVID passes have been issued. A COVID pass could be obtained when either fully vaccinated against COVID-19, or after recovering from a documented COVID-19 episode, or after a recent (24-48 h) negative SARS-CoV-2 antigen test. A global analysis of SARS-CoV-2 immune status determined by past infection and/or vaccination, vaccination rates, as well as societal restrictions in controlling the COVID-19 pandemic is presented. The data show that across the world, vaccination was more effective in reducing SARS-CoV-2 infections with the delta variant than the omicron variant. Strict societal restrictions could control spread of the virus, but relief of the restrictions was associated with an increase in omicron infections. No significant difference in SARS-CoV-2 infections were found when comparing countries or territories which did or did not implement a COVID pass.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Association between Compliance with COVID-19 Restrictions and the Risk of SARS-CoV-2 Infection in Poland
    Hoffmann, Karolina
    Michalak, Michal
    Bonka, Aleksandra
    Bryl, Wieslaw
    Myslinski, Wojciech
    Kostrzewska, Magdalena
    Kopciuch, Dorota
    Zaprutko, Tomasz
    Ratajczak, Piotr
    Nowakowska, Elzbieta
    Kus, Krzysztof
    Paczkowska, Anna
    HEALTHCARE, 2023, 11 (06)
  • [42] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [43] Perspective: SARS-CoV-2, COVID-19 and Haematologists
    Gale, Robert Peter
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 117 - 120
  • [44] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [45] Computation to Fight SARS-CoV-2 (COVID-19)
    Brogi, Simone
    Calderone, Vincenzo
    COMPUTATION, 2023, 11 (09)
  • [46] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [47] SARS-CoV-2/COVID-19: a primer for cardiologists
    A. A. F. de Vries
    Netherlands Heart Journal, 2020, 28 : 366 - 383
  • [48] Decoding Covid-19 with the SARS-CoV-2 Genome
    Phoebe Ellis
    Ferenc Somogyvári
    Dezső P. Virok
    Michela Noseda
    Gary R. McLean
    Current Genetic Medicine Reports, 2021, 9 : 1 - 12
  • [49] In Focus: SARS-CoV-2 and the COVID-19 Pandemic
    Giunta, Riccardo E.
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2020, 52 (03) : 220 - 220
  • [50] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11